DCGI approves clinical trials of Biological E. Covid-19 vaccine CORBEVAX

What is the News? Drugs Controller General of India (DCGI) has approved the Phase II/III clinical trials of the CORBEVAX vaccine in children aged above 5 years. It has also received the nod for conducting Phase III trials in adults. About CORBEVAX Vaccine: CORBEVAX is an indigenously produced COVID-19 vaccine candidate developed by the Indian… Continue reading DCGI approves clinical trials of Biological E. Covid-19 vaccine CORBEVAX